[Clinical use of a new vasoactive drug : nicergoline].
D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D004873:Ergolines / Q000494:pharmacology / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy; D006327:Heart Block / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy; D008297:Male; D008569:Memory Disorders / Q000188:drug therapy; D008875:Middle Aged; D014652:Vascular Diseases / Q000188:drug therapy*; D014653:Vascular Headaches / Q000188:drug therapy; D014786:Vision Disorders / Q000188:drug therapy
D004873:Ergolines
Considerazioni sull'impiego clinico di un nuovo farmaco vasoattivo: la nicergolina.